Our research involves the modification of a recently patented molecule that contains L-3,4-dihydroxyphenylalanine (DOPA) and other bonding peptides to increase osseointegration on metal surfaces, particularly titanium. Lab results show that when coated with this molecule, titanium surfaces showed increased signs of bio-compatibility, which is backed up by published scientific research. The technology has the potential of improving osteosynthesis and orthopedic implants, as well as many other types of surgical implants. The BBZ is looking for licensing, joint R&D, or ownership opportunities regarding this technology.
Cell adhesion on biologically-compatible materials is considered essential for long-term implant biocompatibility. Our research involves the modification of a recently patented molecule that contains L-3,4-dihydroxyphenylalanine (DOPA) and other bonding peptides to increase osseointegration on metal surfaces, particularly titanium. Lab results have been encouraging: when coated with this molecule, titanium surfaces showed increased cell counts, survival rates, and overall health compared to non-treated surfaces. Furthermore, the peptide showed outstanding stability in aqueous solutions. This is backed up by published research attached to this offer. Attached is additional information regarding our technology offer.
The technology offers the following advantages:
Applications
Development of more bio-compatible surgical implants or medical devices where osseointegration is a key aspect of implantation success. Examples include dental, orthopedic, and spine implants, which are typically made using bio-compatible materials such as titanium.
Current development status
Experimental technologies
Desired business relationship
Technology selling
Patent licensing
Technology development
Other
The Centre for Biotechnology and Biomedicine (BBZ) was founded in 2003 as the central research institute of the Leipzig University.
The BBZ promotes the networking of research within the university while simultaneously utilizing emerging interdisciplinary synergies. In cooperation with biotechnologically relevant groups in a life-science network at the Leipzig University, it has been possible to promote the outstanding development in biotechnology with national and international visibility and competitiveness.
Knowledge- and experience-intensive areas of innovation are for the biotechnology industry in Leipzig of great importance. In addition to high-level applied and fundamental research, the BBZ has successfully established an internationally competitive development and implementation platform. Due to its competence and capacity, the BBZ also provides technological consultation for research and industry partners.
Create your free account to connect with Biomedicine and Biotechnology Center - Leipzig University and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Biomedicine and Biotechnology Center - Leipzig University
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
